Shareholder plans sale of 571,967 shares

A shareholder has filed a Form 144 notice to sell 571,967 shares of common stock through The Charles Schwab Corporation on NASDAQ.

Accepted by SEC EDGAR 01/20/2026 - 11:05 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder has filed a Form 144 notice to sell 571,967 shares of common stock through The Charles Schwab Corporation on NASDAQ. The proposed sale has an aggregate market value of $5,909,546.00, with an approximate sale date of 01/20/2026. The filing indicates these shares were acquired from the issuer on 12/31/2013 by various methods and dates, with the full 571,967 shares acquired and paid for on that date. The table also shows that 984,965,179 shares of this class of common stock are outstanding. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing related to IBRX report?

The Form 144 reports a planned sale of 571,967 shares of common stock under Rule 144, to be executed through The Charles Schwab Corporation on NASDAQ.

How many IBRX shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 571,967 shares of common stock, with an aggregate market value of $5,909,546.00 based on the market data used in the form.

When is the approximate sale date for the IBRX shares in this Form 144?

The Form 144 lists an approximate date of sale of 01/20/2026 for the 571,967 common shares to be sold on NASDAQ.

How and when were the IBRX shares in this Form 144 acquired?

The filing states the 571,967 common shares were acquired from the issuer on 12/31/2013 by various methods & dates, with the amount of securities acquired and the date of payment both shown as 12/31/2013.

How many IBRX common shares are outstanding according to this Form 144?

The securities information table reports that there are 984,965,179 shares of this class of common stock outstanding at the time referenced in the form.

What representation does the selling shareholder make in this Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001647994
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ImmunityBio, Inc.
SEC File Number	001-37507
Address of Issuer	3530 JOHN HOPKINS COURT SAN DIEGO CALIFORNIA 92121
Phone	(844) 696-5235
Name of Person for Whose Account the Securities are To Be Sold	Simon Barry J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	571967	5909546.00	984965179	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/31/2013	VARIOUS METHODS & DATES	ISSUER			571967	12/31/2013	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/04/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	BARRY J. SIMON
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)